Solstein Capital LLC raised its holdings in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 7.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,277 shares of the company’s stock after acquiring an additional 237 shares during the period. Solstein Capital LLC’s holdings in Procter & Gamble were worth $522,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the business. Envestnet Asset Management Inc. raised its holdings in shares of Procter & Gamble by 1.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 3,458,520 shares of the company’s stock valued at $550,894,000 after acquiring an additional 60,034 shares in the last quarter. Chilton Capital Management LLC raised its holdings in shares of Procter & Gamble by 4.3% in the 2nd quarter. Chilton Capital Management LLC now owns 198,708 shares of the company’s stock valued at $31,658,000 after acquiring an additional 8,170 shares in the last quarter. Resonant Capital Advisors LLC raised its holdings in shares of Procter & Gamble by 7.5% in the 2nd quarter. Resonant Capital Advisors LLC now owns 27,568 shares of the company’s stock valued at $4,392,000 after acquiring an additional 1,916 shares in the last quarter. Oppenheimer Asset Management Inc. raised its holdings in shares of Procter & Gamble by 4.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 67,124 shares of the company’s stock valued at $10,694,000 after acquiring an additional 3,042 shares in the last quarter. Finally, Guardian Wealth Advisors LLC increased its position in shares of Procter & Gamble by 5.6% during the 2nd quarter. Guardian Wealth Advisors LLC now owns 4,530 shares of the company’s stock valued at $722,000 after purchasing an additional 241 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Analyst Upgrades and Downgrades
PG has been the topic of several recent research reports. Evercore ISI reiterated an “in-line” rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Berenberg Bank increased their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research report on Friday, October 10th. Wells Fargo & Company reduced their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Finally, BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $171.68.
Insider Transactions at Procter & Gamble
In other news, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $606,788.78. Following the sale, the chief operating officer directly owned 46,899 shares in the company, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 4,252 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares in the company, valued at approximately $8,219,202.16. This represents a 7.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 149,763 shares of company stock worth $23,421,279. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Price Performance
PG opened at $152.62 on Monday. The stock’s 50 day simple moving average is $154.66 and its 200 day simple moving average is $158.38. The company has a debt-to-equity ratio of 0.45, a current ratio of 0.71 and a quick ratio of 0.51. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43. The firm has a market cap of $357.21 billion, a price-to-earnings ratio of 22.28, a PEG ratio of 4.05 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.51% and a net margin of 19.74%.The business had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same period last year, the company earned $1.93 EPS. Procter & Gamble’s revenue for the quarter was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is currently 64.98%.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
